Cataligo Manganese - D4 Liq 4 D Liquid is a Health Canada–registered human drug (DIN 02121085) held by Laboratoires Holis Inc., containing Manganese. Health Canada lists its status as Cancelled Post Market (status date 12 Jan 1998). Nexara Health has matched 17 registrations of Manganese across 3 other regulated markets.
Health Canada registration
| DIN | 02121085 |
|---|---|
| Brand name | Cataligo Manganese - D4 Liq |
| Active ingredient | Manganese |
| Strength | 4 D |
| Dosage form | Liquid |
| Route | Oral |
| Company | Laboratoires Holis Inc. |
| Status | Cancelled Post Market — 12 Jan 1998 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Manganese registered in other markets
17 registrations of the same molecule in 3 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| MA | Tothema | — | 50 / 1.33 MG / MG | Solution Buvable | P | CNOPS liste des medicaments |
| Taiwan | Manganese Citrate Soluble,"Parke Davis" | Parke-Davis , Division Of Warner Lambert Company | （粉） | 已註銷 | TFDA | |
| United States | Bestmade Natural Products Manganese Sulfate (Mang Sulf) | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| United States | BM Manganese sulfate (Mang Sulf) | BM Private Limited | Tablet | listed | FDA NDC | |
| United States | Manganese | Fresenius Kabi USA, LLC | Injection, Solution | listed | FDA NDC | |
| United States | Manganese | Hospira, Inc. | Injection, Solution | listed | FDA NDC | |
| United States | Manganese Citrate | Jost Chemical Co. | Powder | FDA NDC | ||
| United States | Manganese Gluconate | Spectrum Laboratory Products, Inc. | Powder | FDA NDC | ||
| United States | Manganese Gluconate Dihydrate | Jost Chemical Co. | Granule | FDA NDC | ||
| United States | Manganese Sulfate | Spectrum Laboratory Products, Inc. | Powder | FDA NDC |
See every manufacturer of Manganese worldwide →
Regulator price references for Manganese
Published list or reimbursement prices for Manganese presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.
| Country | Product | Strength | Pack | Price | Type | Source | As of |
|---|---|---|---|---|---|---|---|
| MA | Tothema | 1.33mg/1mg | 1 BOITE 20 AMPOULE BUVABLE | 42.20 MAD | PPV (public price) | CNOPS liste des medicaments | 2026-09-05 |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Cataligo Manganese - D4 Liq (DIN 02121085) marketed in Canada?
No. Health Canada lists DIN 02121085 as Cancelled Post Market as of 12 Jan 1998.
Who holds the Canadian licence for this product?
Laboratoires Holis Inc. is the company of record in the Health Canada Drug Product Database.
Is Manganese registered outside Canada?
Yes — Nexara Health has matched 17 registrations in 3 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02121085, status date 1998-01-12; national medicine registries: CNOPS liste des medicaments, FDA NDC, TFDA; price sources: CNOPS liste des medicaments. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02121085, status date 1998-01-12; national medicine registries: CNOPS liste des medicaments, FDA NDC, TFDA; price sources: CNOPS liste des medicaments.
Health Canada Drug Product Database (DPD), DIN 02121085, status date 1998-01-12; national medicine registries: CNOPS liste des medicaments, FDA NDC, TFDA; price sources: CNOPS liste des medicaments. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.